| Q94881859 | Q94881859 |
| Q34085383 | Ablate and pace: palliating the symptoms? |
| Q40879013 | Ablation therapy for cardiac arrhythmias |
| Q48511434 | Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block |
| Q73193633 | American College of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. A report of the American College of Cardiology/American Heart Association/American C |
| Q37109810 | Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients |
| Q37855664 | Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome |
| Q41250509 | Atrioventricular junctional ablation and modification for atrial fibrillation |
| Q36830731 | Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials |
| Q35566104 | Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia |
| Q70834576 | Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center |
| Q30464453 | Correlation of Temperature and Pathophysiological Effect During Radiofrequency Catheter Ablation of the AV Junction |
| Q57249899 | Cryoablation for curing reciprocating tachycardia: take the good and leave the bad |
| Q38053185 | Current role of atrioventricular junction (AVJ) ablation |
| Q43224274 | Electroporation: past and future of catheter ablation |
| Q36582186 | Evolution of curative therapies for atrial fibrillation review. |
| Q51942066 | Health-related quality of life in patients newly diagnosed with atrial fibrillation. |
| Q35168786 | Hybrid therapy in the management of atrial fibrillation. |
| Q71907192 | Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response |
| Q44393649 | Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation |
| Q74012833 | Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation |
| Q71244142 | Lack of proarrhythmia as assessed by Holter monitor after atrial radiofrequency ablation of supraventricular tachycardia in children |
| Q71975697 | Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation |
| Q73319796 | Long-term pacemaker dependency after radiofrequency ablation of the atrioventricular junction |
| Q71880181 | Microwave ablation of the atrioventricular junction in open‐chest dogs |
| Q41001483 | Prediction of the location and time of spontaneous termination of reentrant ventricular tachycardia for radiofrequency catheter ablation therapy |
| Q77958204 | Prolonged QT interval and altered QT/RR relation early after radiofrequency ablation of the atrioventricular junction |
| Q84596232 | Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up |
| Q44284914 | Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation |
| Q71847536 | Quality of life in patients with atrial fibrillation |
| Q41664559 | Radiofrequency catheter ablation for atrial fibrillation. |
| Q54058028 | Short term escape rhythm characteristics after radiofrequency ablation of the atrioventricular junction. |
| Q54440472 | Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. |
| Q40538838 | Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation. |
| Q39472360 | Supraventricular tachyarrhythmias: Pharrnacologic versus nonpharrnacologic approaches |
| Q40607802 | Supraventricular tachyarrhythmias: drug therapy versus catheter ablation. |
| Q53563663 | The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. |
| Q41352642 | The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies |
| Q42544877 | Torsade de pointes secondary to d,l-sotalol after catheter ablation of incessant atrioventricular reentrant tachycardia--evidence for a significant contribution of the "cardiac memory". |
| Q73024612 | Torsades de pointes following radiofrequency catheter His ablation |
| Q30471976 | Treatment strategies for atrial fibrillation |
| Q37115119 | Two-Year Follow-up in Atrial Fibrillation Patients Referred for Catheter Ablation of the Atrioventricular Node |
| Q74603956 | [Hemodynamic deterioration in patients submitted to ablation of the atrioventricular node] |